

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | axoneme assembly (GO:0035082) | 8.14833644 |
| 2 | intestinal epithelial cell development (GO:0060576) | 7.57299573 |
| 3 | left/right pattern formation (GO:0060972) | 7.33373730 |
| 4 | diterpenoid biosynthetic process (GO:0016102) | 6.90968511 |
| 5 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 6.81451458 |
| 6 | artery development (GO:0060840) | 6.63919748 |
| 7 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 6.49402802 |
| 8 | sulfur amino acid catabolic process (GO:0000098) | 6.40676334 |
| 9 | regulation of cilium movement (GO:0003352) | 6.09200115 |
| 10 | branching involved in prostate gland morphogenesis (GO:0060442) | 5.99366735 |
| 11 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 5.60872861 |
| 12 | regulation of guanylate cyclase activity (GO:0031282) | 5.53846655 |
| 13 | left/right axis specification (GO:0070986) | 5.40969734 |
| 14 | sperm capacitation (GO:0048240) | 5.28529050 |
| 15 | ventricular system development (GO:0021591) | 5.14586799 |
| 16 | L-fucose catabolic process (GO:0042355) | 5.13731794 |
| 17 | fucose catabolic process (GO:0019317) | 5.13731794 |
| 18 | L-fucose metabolic process (GO:0042354) | 5.13731794 |
| 19 | bile acid and bile salt transport (GO:0015721) | 5.11374752 |
| 20 | microtubule bundle formation (GO:0001578) | 5.09775927 |
| 21 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis (GO:006052 | 5.09239542 |
| 22 | maintenance of gastrointestinal epithelium (GO:0030277) | 5.03200333 |
| 23 | one-carbon compound transport (GO:0019755) | 5.01444024 |
| 24 | galactose catabolic process (GO:0019388) | 5.01393712 |
| 25 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 4.96197340 |
| 26 | hypotonic response (GO:0006971) | 4.83192095 |
| 27 | terpenoid biosynthetic process (GO:0016114) | 4.77178080 |
| 28 | desmosome organization (GO:0002934) | 4.68879811 |
| 29 | intraciliary transport (GO:0042073) | 4.58410858 |
| 30 | lung epithelium development (GO:0060428) | 4.56800224 |
| 31 | retinoic acid metabolic process (GO:0042573) | 4.56378289 |
| 32 | positive regulation of guanylate cyclase activity (GO:0031284) | 4.47643682 |
| 33 | lung secretory cell differentiation (GO:0061140) | 4.46771761 |
| 34 | negative regulation of T cell differentiation in thymus (GO:0033085) | 4.45377252 |
| 35 | sulfate transmembrane transport (GO:1902358) | 4.41942178 |
| 36 | nucleotide-sugar biosynthetic process (GO:0009226) | 4.41610456 |
| 37 | tolerance induction (GO:0002507) | 4.41566508 |
| 38 | cilium organization (GO:0044782) | 4.41106689 |
| 39 | establishment of apical/basal cell polarity (GO:0035089) | 4.29628817 |
| 40 | glomerular epithelial cell development (GO:0072310) | 4.29218608 |
| 41 | cellular ketone body metabolic process (GO:0046950) | 4.29089271 |
| 42 | cilium assembly (GO:0042384) | 4.28571401 |
| 43 | response to xenobiotic stimulus (GO:0009410) | 4.22564714 |
| 44 | negative regulation of humoral immune response (GO:0002921) | 4.17175761 |
| 45 | oligosaccharide biosynthetic process (GO:0009312) | 4.16662113 |
| 46 | hemidesmosome assembly (GO:0031581) | 4.15979004 |
| 47 | O-glycan processing (GO:0016266) | 4.11433489 |
| 48 | primary alcohol metabolic process (GO:0034308) | 4.08517134 |
| 49 | N-glycan processing (GO:0006491) | 4.07350993 |
| 50 | epithelial structure maintenance (GO:0010669) | 3.99183967 |
| 51 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.98464747 |
| 52 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.98464747 |
| 53 | retinol metabolic process (GO:0042572) | 3.97125074 |
| 54 | regulation of interleukin-5 production (GO:0032674) | 3.94721813 |
| 55 | fucose metabolic process (GO:0006004) | 3.83937907 |
| 56 | centriole assembly (GO:0098534) | 3.82562727 |
| 57 | antibacterial humoral response (GO:0019731) | 3.82208886 |
| 58 | negative regulation of B cell mediated immunity (GO:0002713) | 3.80503069 |
| 59 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 3.80503069 |
| 60 | nucleotide-sugar metabolic process (GO:0009225) | 3.76036245 |
| 61 | regulation of protein glycosylation (GO:0060049) | 3.73294621 |
| 62 | positive regulation of glycoprotein metabolic process (GO:1903020) | 3.71008597 |
| 63 | ketone body metabolic process (GO:1902224) | 3.69975721 |
| 64 | regulation of interleukin-13 production (GO:0032656) | 3.69424153 |
| 65 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.68889013 |
| 66 | GDP-mannose metabolic process (GO:0019673) | 3.64734074 |
| 67 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.64023989 |
| 68 | regulation of cell-cell adhesion mediated by cadherin (GO:2000047) | 3.63389164 |
| 69 | negative regulation of protein tyrosine kinase activity (GO:0061099) | 3.62512864 |
| 70 | antimicrobial humoral response (GO:0019730) | 3.61991247 |
| 71 | establishment of monopolar cell polarity (GO:0061162) | 3.59527748 |
| 72 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 3.59527748 |
| 73 | cGMP-mediated signaling (GO:0019934) | 3.59497536 |
| 74 | prostate gland epithelium morphogenesis (GO:0060740) | 3.58956364 |
| 75 | glandular epithelial cell differentiation (GO:0002067) | 3.58080353 |
| 76 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.54757573 |
| 77 | regulation of cGMP biosynthetic process (GO:0030826) | 3.54649656 |
| 78 | exogenous drug catabolic process (GO:0042738) | 3.53110466 |
| 79 | sulfate transport (GO:0008272) | 3.52793968 |
| 80 | ethanol metabolic process (GO:0006067) | 3.52412590 |
| 81 | regulation of germinal center formation (GO:0002634) | 3.50954489 |
| 82 | microtubule-based movement (GO:0007018) | 3.50909075 |
| 83 | regulation of microtubule-based movement (GO:0060632) | 3.50835292 |
| 84 | phosphatidylcholine biosynthetic process (GO:0006656) | 3.50048713 |
| 85 | protein localization to cilium (GO:0061512) | 3.49367832 |
| 86 | L-serine transport (GO:0015825) | 3.47449018 |
| 87 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 3.45837983 |
| 88 | ethanol oxidation (GO:0006069) | 3.44885410 |
| 89 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.42539504 |
| 90 | transcytosis (GO:0045056) | 3.40778548 |
| 91 | excretion (GO:0007588) | 3.40152759 |
| 92 | morphogenesis of an epithelial fold (GO:0060571) | 3.38529575 |
| 93 | mannose metabolic process (GO:0006013) | 3.38306322 |
| 94 | cell projection assembly (GO:0030031) | 3.37942559 |
| 95 | cellular component assembly involved in morphogenesis (GO:0010927) | 3.36557417 |
| 96 | actin filament depolymerization (GO:0030042) | 3.34409107 |
| 97 | epithelial cell maturation (GO:0002070) | 3.32588781 |
| 98 | progesterone metabolic process (GO:0042448) | 3.32031667 |
| 99 | water homeostasis (GO:0030104) | 3.31904613 |
| 100 | regulation of T cell tolerance induction (GO:0002664) | 3.26424794 |
| 101 | glutathione derivative biosynthetic process (GO:1901687) | 3.21713443 |
| 102 | glutathione derivative metabolic process (GO:1901685) | 3.21713443 |
| 103 | Golgi transport vesicle coating (GO:0048200) | 3.21364473 |
| 104 | COPI coating of Golgi vesicle (GO:0048205) | 3.21364473 |
| 105 | sodium ion homeostasis (GO:0055078) | 3.20836742 |
| 106 | regulation of water loss via skin (GO:0033561) | 3.19053415 |
| 107 | primary alcohol catabolic process (GO:0034310) | 3.18095708 |
| 108 | galactose metabolic process (GO:0006012) | 3.17382282 |
| 109 | protein O-linked glycosylation (GO:0006493) | 3.16125391 |
| 110 | neurotransmitter biosynthetic process (GO:0042136) | 3.15587057 |
| 111 | hepatocyte apoptotic process (GO:0097284) | 3.12658971 |
| 112 | regulation of pH (GO:0006885) | 3.11118972 |
| 113 | hexose catabolic process (GO:0019320) | 3.11023797 |
| 114 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.10992871 |
| 115 | cytoplasmic microtubule organization (GO:0031122) | 3.10233476 |
| 116 | epithelial cell-cell adhesion (GO:0090136) | 3.08764572 |
| 117 | macrophage chemotaxis (GO:0048246) | 3.07483969 |
| 118 | bicarbonate transport (GO:0015701) | 3.04236918 |
| 119 | establishment of planar polarity (GO:0001736) | 3.02724881 |
| 120 | establishment of tissue polarity (GO:0007164) | 3.02724881 |
| 121 | diol metabolic process (GO:0034311) | 3.01849526 |
| 122 | negative regulation of inclusion body assembly (GO:0090084) | 3.00821190 |
| 123 | multicellular organismal water homeostasis (GO:0050891) | 3.00226369 |
| 124 | nucleoside diphosphate phosphorylation (GO:0006165) | 2.99826565 |
| 125 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.99602868 |
| 126 | tight junction assembly (GO:0070830) | 2.93494366 |
| 127 | cilium morphogenesis (GO:0060271) | 2.93329565 |
| 128 | negative regulation of protein autophosphorylation (GO:0031953) | 2.93115744 |
| 129 | DNA damage induced protein phosphorylation (GO:0006975) | 2.92339942 |
| 130 | serine transport (GO:0032329) | 2.91009844 |
| 131 | regulation of tolerance induction (GO:0002643) | 2.90737256 |
| 132 | regulation of cGMP metabolic process (GO:0030823) | 2.90708243 |
| 133 | cytidine deamination (GO:0009972) | 2.90088091 |
| 134 | cytidine metabolic process (GO:0046087) | 2.90088091 |
| 135 | cytidine catabolic process (GO:0006216) | 2.90088091 |
| 136 | drug catabolic process (GO:0042737) | 2.88644399 |
| 137 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.87594406 |
| 138 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.86199577 |
| 139 | glutathione biosynthetic process (GO:0006750) | 2.85950174 |
| 140 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.85549772 |
| 141 | potassium ion homeostasis (GO:0055075) | 2.83940679 |
| 142 | columnar/cuboidal epithelial cell development (GO:0002066) | 2.82554031 |
| 143 | cellular zinc ion homeostasis (GO:0006882) | 2.82508856 |
| 144 | positive regulation of tolerance induction (GO:0002645) | 2.82374678 |
| 145 | positive regulation of cGMP biosynthetic process (GO:0030828) | 2.80459848 |
| 146 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.76653685 |
| 147 | hormone catabolic process (GO:0042447) | 2.76569238 |
| 148 | carnitine metabolic process (GO:0009437) | 2.76487067 |
| 149 | hydrogen peroxide catabolic process (GO:0042744) | 2.74988846 |
| 150 | regulation of receptor binding (GO:1900120) | 2.74476066 |
| 151 | cell communication involved in cardiac conduction (GO:0086065) | 2.72574713 |
| 152 | flavonoid metabolic process (GO:0009812) | 2.72060665 |
| 153 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.71983691 |
| 154 | establishment of skin barrier (GO:0061436) | 2.70404851 |
| 155 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.69740536 |
| 156 | phosphatidylserine metabolic process (GO:0006658) | 2.69222539 |
| 157 | regulation of autophagic vacuole assembly (GO:2000785) | 2.68904094 |
| 158 | positive regulation of smoothened signaling pathway (GO:0045880) | 2.68657885 |
| 159 | regulation of vitamin metabolic process (GO:0030656) | 2.68471425 |
| 160 | zinc ion transport (GO:0006829) | 2.67292465 |
| 161 | regulation of histone phosphorylation (GO:0033127) | 2.67207739 |
| 162 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.65646727 |
| 163 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.65621627 |
| 164 | monosaccharide catabolic process (GO:0046365) | 2.64711836 |
| 165 | glutathione metabolic process (GO:0006749) | 2.64653908 |
| 166 | apical protein localization (GO:0045176) | 2.63356954 |
| 167 | regulation of metalloenzyme activity (GO:0048552) | 2.62774402 |
| 168 | renal absorption (GO:0070293) | 2.59194881 |
| 169 | hydrogen peroxide metabolic process (GO:0042743) | 2.58473015 |
| 170 | establishment or maintenance of apical/basal cell polarity (GO:0035088) | 2.57074529 |
| 171 | establishment or maintenance of bipolar cell polarity (GO:0061245) | 2.57074529 |
| 172 | sphingomyelin metabolic process (GO:0006684) | 2.55954302 |
| 173 | carnitine transmembrane transport (GO:1902603) | 2.52329553 |
| 174 | epoxygenase P450 pathway (GO:0019373) | 2.50446830 |
| 175 | positive regulation of respiratory burst (GO:0060267) | 2.49693639 |
| 176 | microtubule depolymerization (GO:0007019) | 2.44516050 |
| 177 | phenol-containing compound catabolic process (GO:0019336) | 2.43936775 |
| 178 | polyol transport (GO:0015791) | 2.43779703 |
| 179 | reactive oxygen species biosynthetic process (GO:1903409) | 2.42214581 |
| 180 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 2.41816886 |
| 181 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.40758679 |
| 182 | axonemal dynein complex assembly (GO:0070286) | 18.3063729 |
| 183 | cilium or flagellum-dependent cell motility (GO:0001539) | 14.7482643 |
| 184 | cilium movement (GO:0003341) | 12.6795207 |
| 185 | motile cilium assembly (GO:0044458) | 12.4246558 |
| 186 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 11.2197080 |
| 187 | epithelial cilium movement (GO:0003351) | 10.8091682 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.80727035 |
| 2 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 3.98871286 |
| 3 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.76212955 |
| 4 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 3.46270878 |
| 5 | * SOX2_20726797_ChIP-Seq_SW620_Human | 3.19073414 |
| 6 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 3.13227523 |
| 7 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.85306763 |
| 8 | GATA6_25053715_ChIP-Seq_YYC3_Human | 2.75198905 |
| 9 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.72809286 |
| 10 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.71505821 |
| 11 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.65733783 |
| 12 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.60258401 |
| 13 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.51627232 |
| 14 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.19928500 |
| 15 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.18874430 |
| 16 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 2.18363606 |
| 17 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.14500039 |
| 18 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.11170655 |
| 19 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.10307487 |
| 20 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 2.09956209 |
| 21 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.09048780 |
| 22 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.06901199 |
| 23 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.00231531 |
| 24 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.95570334 |
| 25 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.90366396 |
| 26 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.89851356 |
| 27 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.89383693 |
| 28 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.88783274 |
| 29 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.86967280 |
| 30 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.84817687 |
| 31 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.82004662 |
| 32 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.80934963 |
| 33 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.80840624 |
| 34 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.80394448 |
| 35 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.79938778 |
| 36 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.78894468 |
| 37 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.77528279 |
| 38 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.75360661 |
| 39 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.71977091 |
| 40 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.68578225 |
| 41 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.68485245 |
| 42 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.67070861 |
| 43 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.64103697 |
| 44 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.63944651 |
| 45 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.62974873 |
| 46 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.62230457 |
| 47 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.62230457 |
| 48 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.60324227 |
| 49 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.59946609 |
| 50 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.55363444 |
| 51 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.55215621 |
| 52 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.53562255 |
| 53 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.51286774 |
| 54 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.50996350 |
| 55 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.49635985 |
| 56 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.45356927 |
| 57 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.45252726 |
| 58 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.43081155 |
| 59 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.41894509 |
| 60 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.40419179 |
| 61 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.40352566 |
| 62 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.39447908 |
| 63 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.38560588 |
| 64 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.37907550 |
| 65 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.36529364 |
| 66 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.35941404 |
| 67 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.35830796 |
| 68 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.33868835 |
| 69 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.33018593 |
| 70 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.29153860 |
| 71 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.28479212 |
| 72 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.25336893 |
| 73 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.24779649 |
| 74 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.22992852 |
| 75 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.22898998 |
| 76 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.22898998 |
| 77 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.21577315 |
| 78 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.18223282 |
| 79 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.18223282 |
| 80 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.18223282 |
| 81 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.17762493 |
| 82 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.16312728 |
| 83 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.14142678 |
| 84 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.13215208 |
| 85 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.13004496 |
| 86 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.12304600 |
| 87 | RXR_22108803_ChIP-Seq_LS180_Human | 1.09583007 |
| 88 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.09214447 |
| 89 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.07799359 |
| 90 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.07411680 |
| 91 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.07071910 |
| 92 | P68_20966046_ChIP-Seq_HELA_Human | 1.05124173 |
| 93 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.04478788 |
| 94 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.03980150 |
| 95 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.02907194 |
| 96 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.02522218 |
| 97 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.01363149 |
| 98 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.99811790 |
| 99 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.98821812 |
| 100 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.98736017 |
| 101 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.98614393 |
| 102 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.96888955 |
| 103 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.96042604 |
| 104 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.95432280 |
| 105 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.95310223 |
| 106 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.94792201 |
| 107 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.93472291 |
| 108 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.93308233 |
| 109 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.92978450 |
| 110 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.92551445 |
| 111 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.92284624 |
| 112 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.92164243 |
| 113 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.91541666 |
| 114 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.91220097 |
| 115 | * ETV1_20927104_ChIP-Seq_GIST48_Human | 0.89898143 |
| 116 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.88784565 |
| 117 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.88724681 |
| 118 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.88221853 |
| 119 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.87982485 |
| 120 | * HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.87427532 |
| 121 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.87427443 |
| 122 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.86867187 |
| 123 | * PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.86831958 |
| 124 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.85899650 |
| 125 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.85819956 |
| 126 | * CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.84275655 |
| 127 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.84148311 |
| 128 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.83237327 |
| 129 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.82546519 |
| 130 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.82546519 |
| 131 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.82007298 |
| 132 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.81322416 |
| 133 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.81148131 |
| 134 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.80928151 |
| 135 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.80830002 |
| 136 | * RBPJ_21746931_ChIP-Seq_IB4_Human | 0.80392565 |
| 137 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.80367233 |
| 138 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.79809933 |
| 139 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.79527978 |
| 140 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.78695643 |
| 141 | * PHF8_20622853_ChIP-Seq_HELA_Human | 0.77864939 |
| 142 | * P300_27268052_Chip-Seq_Bcells_Human | 0.77774348 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010234_abnormal_vibrissa_follicle | 7.83134820 |
| 2 | MP0001873_stomach_inflammation | 4.14739892 |
| 3 | MP0002653_abnormal_ependyma_morphology | 4.06375867 |
| 4 | MP0005377_hearing/vestibular/ear_phenot | 3.90670782 |
| 5 | MP0003878_abnormal_ear_physiology | 3.90670782 |
| 6 | MP0002822_catalepsy | 3.86847536 |
| 7 | MP0004264_abnormal_extraembryonic_tissu | 3.35072573 |
| 8 | MP0003866_abnormal_defecation | 3.20713624 |
| 9 | MP0005257_abnormal_intraocular_pressure | 2.84355804 |
| 10 | MP0000566_synostosis | 2.77570053 |
| 11 | MP0003300_gastrointestinal_ulcer | 2.77193607 |
| 12 | MP0008875_abnormal_xenobiotic_pharmacok | 2.75599654 |
| 13 | MP0004043_abnormal_pH_regulation | 2.74541298 |
| 14 | MP0005310_abnormal_salivary_gland | 2.73437690 |
| 15 | MP0001663_abnormal_digestive_system | 2.56832066 |
| 16 | MP0000537_abnormal_urethra_morphology | 2.56471887 |
| 17 | MP0010155_abnormal_intestine_physiology | 2.48728666 |
| 18 | MP0000678_abnormal_parathyroid_gland | 2.43122658 |
| 19 | MP0005381_digestive/alimentary_phenotyp | 2.40139875 |
| 20 | MP0000462_abnormal_digestive_system | 2.38573162 |
| 21 | MP0000490_abnormal_crypts_of | 2.30236585 |
| 22 | MP0001765_abnormal_ion_homeostasis | 2.25684493 |
| 23 | MP0001666_abnormal_nutrient_absorption | 2.21059467 |
| 24 | MP0002166_altered_tumor_susceptibility | 2.12676240 |
| 25 | MP0009379_abnormal_foot_pigmentation | 2.10187023 |
| 26 | MP0001984_abnormal_olfaction | 2.07899191 |
| 27 | MP0008789_abnormal_olfactory_epithelium | 2.05310084 |
| 28 | MP0003941_abnormal_skin_development | 1.99842691 |
| 29 | MP0001664_abnormal_digestion | 1.99699523 |
| 30 | MP0000477_abnormal_intestine_morphology | 1.96536053 |
| 31 | MP0005058_abnormal_lysosome_morphology | 1.95720564 |
| 32 | MP0005167_abnormal_blood-brain_barrier | 1.89604332 |
| 33 | MP0005623_abnormal_meninges_morphology | 1.89228666 |
| 34 | MP0004133_heterotaxia | 1.87678967 |
| 35 | MP0005083_abnormal_biliary_tract | 1.87279134 |
| 36 | MP0010678_abnormal_skin_adnexa | 1.83393177 |
| 37 | MP0002132_abnormal_respiratory_system | 1.78155150 |
| 38 | MP0003283_abnormal_digestive_organ | 1.70384810 |
| 39 | MP0010352_gastrointestinal_tract_polyps | 1.69580104 |
| 40 | MP0005165_increased_susceptibility_to | 1.66667233 |
| 41 | MP0002168_other_aberrant_phenotype | 1.65557030 |
| 42 | MP0002796_impaired_skin_barrier | 1.62662221 |
| 43 | MP0003191_abnormal_cellular_cholesterol | 1.60740876 |
| 44 | MP0005636_abnormal_mineral_homeostasis | 1.59957838 |
| 45 | MP0010386_abnormal_urinary_bladder | 1.56774113 |
| 46 | MP0001756_abnormal_urination | 1.56683023 |
| 47 | MP0002006_tumorigenesis | 1.56123715 |
| 48 | MP0009643_abnormal_urine_homeostasis | 1.52405977 |
| 49 | MP0000613_abnormal_salivary_gland | 1.50121586 |
| 50 | MP0005409_darkened_coat_color | 1.49450244 |
| 51 | MP0004885_abnormal_endolymph | 1.42402553 |
| 52 | MP0005085_abnormal_gallbladder_physiolo | 1.41496244 |
| 53 | MP0002139_abnormal_hepatobiliary_system | 1.36050956 |
| 54 | MP0004782_abnormal_surfactant_physiolog | 1.34867865 |
| 55 | MP0005166_decreased_susceptibility_to | 1.34188444 |
| 56 | MP0003303_peritoneal_inflammation | 1.32767632 |
| 57 | MP0002277_abnormal_respiratory_mucosa | 1.28851755 |
| 58 | MP0000470_abnormal_stomach_morphology | 1.25967426 |
| 59 | MP0000538_abnormal_urinary_bladder | 1.21148289 |
| 60 | MP0003656_abnormal_erythrocyte_physiolo | 1.19146898 |
| 61 | MP0005647_abnormal_sex_gland | 1.17163732 |
| 62 | MP0003868_abnormal_feces_composition | 1.16262975 |
| 63 | MP0005499_abnormal_olfactory_system | 1.16071339 |
| 64 | MP0005394_taste/olfaction_phenotype | 1.16071339 |
| 65 | MP0008004_abnormal_stomach_pH | 1.14099301 |
| 66 | MP0002009_preneoplasia | 1.13759002 |
| 67 | MP0002098_abnormal_vibrissa_morphology | 1.13530086 |
| 68 | MP0002282_abnormal_trachea_morphology | 1.12105889 |
| 69 | MP0003705_abnormal_hypodermis_morpholog | 1.11767788 |
| 70 | MP0002060_abnormal_skin_morphology | 1.09341329 |
| 71 | MP0003315_abnormal_perineum_morphology | 1.09191558 |
| 72 | MP0004185_abnormal_adipocyte_glucose | 1.07750355 |
| 73 | MP0000681_abnormal_thyroid_gland | 1.06400729 |
| 74 | MP0001346_abnormal_lacrimal_gland | 1.05500830 |
| 75 | MP0006054_spinal_hemorrhage | 1.05331525 |
| 76 | MP0005395_other_phenotype | 1.02980850 |
| 77 | MP0004019_abnormal_vitamin_homeostasis | 1.01084693 |
| 78 | MP0002249_abnormal_larynx_morphology | 1.00688220 |
| 79 | MP0003453_abnormal_keratinocyte_physiol | 0.98696996 |
| 80 | MP0005365_abnormal_bile_salt | 0.98209365 |
| 81 | MP0005360_urolithiasis | 0.96016170 |
| 82 | MP0000465_gastrointestinal_hemorrhage | 0.94385649 |
| 83 | MP0000858_altered_metastatic_potential | 0.94021172 |
| 84 | MP0004947_skin_inflammation | 0.92730976 |
| 85 | MP0002136_abnormal_kidney_physiology | 0.92632503 |
| 86 | MP0005248_abnormal_Harderian_gland | 0.91560053 |
| 87 | MP0002160_abnormal_reproductive_system | 0.91412472 |
| 88 | MP0001216_abnormal_epidermal_layer | 0.90232957 |
| 89 | MP0005164_abnormal_response_to | 0.88665370 |
| 90 | MP0003075_altered_response_to | 0.87053242 |
| 91 | MP0002234_abnormal_pharynx_morphology | 0.84545873 |
| 92 | MP0000762_abnormal_tongue_morphology | 0.83311182 |
| 93 | MP0009780_abnormal_chondrocyte_physiolo | 0.82067049 |
| 94 | MP0001849_ear_inflammation | 0.81270869 |
| 95 | MP0005501_abnormal_skin_physiology | 0.79005350 |
| 96 | MP0009384_cardiac_valve_regurgitation | 0.78832802 |
| 97 | MP0000383_abnormal_hair_follicle | 0.78566613 |
| 98 | MP0003045_fibrosis | 0.77399541 |
| 99 | MP0008872_abnormal_physiological_respon | 0.77189653 |
| 100 | MP0005408_hypopigmentation | 0.74320500 |
| 101 | MP0002909_abnormal_adrenal_gland | 0.71853323 |
| 102 | MP0006082_CNS_inflammation | 0.70820010 |
| 103 | MP0003566_abnormal_cell_adhesion | 0.70196916 |
| 104 | MP0005367_renal/urinary_system_phenotyp | 0.69496973 |
| 105 | MP0000516_abnormal_urinary_system | 0.69496973 |
| 106 | MP0004858_abnormal_nervous_system | 0.69444466 |
| 107 | MP0003183_abnormal_peptide_metabolism | 0.68352737 |
| 108 | MP0003252_abnormal_bile_duct | 0.67737797 |
| 109 | MP0002295_abnormal_pulmonary_circulatio | 0.67610265 |
| 110 | MP0008873_increased_physiological_sensi | 0.66884097 |
| 111 | MP0001485_abnormal_pinna_reflex | 0.66795208 |
| 112 | MP0004484_altered_response_of | 0.66641530 |
| 113 | MP0005076_abnormal_cell_differentiation | 0.64742850 |
| 114 | MP0009785_altered_susceptibility_to | 0.64566973 |
| 115 | MP0000467_abnormal_esophagus_morphology | 0.63327653 |
| 116 | MP0005387_immune_system_phenotype | 0.61709526 |
| 117 | MP0001790_abnormal_immune_system | 0.61709526 |
| 118 | MP0005319_abnormal_enzyme/_coenzyme | 0.61201526 |
| 119 | MP0005023_abnormal_wound_healing | 0.59920152 |
| 120 | MP0002876_abnormal_thyroid_physiology | 0.59791265 |
| 121 | MP0004883_abnormal_blood_vessel | 0.56874187 |
| 122 | MP0003806_abnormal_nucleotide_metabolis | 0.56558863 |
| 123 | MP0010771_integument_phenotype | 0.56379185 |
| 124 | MP0009764_decreased_sensitivity_to | 0.55534236 |
| 125 | MP0000579_abnormal_nail_morphology | 0.54463651 |
| 126 | MP0000013_abnormal_adipose_tissue | 0.52383663 |
| 127 | MP0001845_abnormal_inflammatory_respons | 0.52262544 |
| 128 | MP0001188_hyperpigmentation | 0.51595714 |
| 129 | MP0005275_abnormal_skin_tensile | 0.50396470 |
| 130 | MP0009765_abnormal_xenobiotic_induced | 0.49761036 |
| 131 | MP0002896_abnormal_bone_mineralization | 0.49128713 |
| 132 | MP0003879_abnormal_hair_cell | 0.48963798 |
| 133 | MP0000377_abnormal_hair_follicle | 0.48660260 |
| 134 | MP0005025_abnormal_response_to | 0.48645676 |
| 135 | MP0003950_abnormal_plasma_membrane | 0.47791388 |
| 136 | MP0000534_abnormal_ureter_morphology | 0.47545332 |
| 137 | MP0005220_abnormal_exocrine_pancreas | 0.47539651 |
| 138 | MP0002233_abnormal_nose_morphology | 0.47222474 |
| 139 | MP0000249_abnormal_blood_vessel | 0.46440996 |
| 140 | MP0005187_abnormal_penis_morphology | 0.46015016 |
| 141 | MP0002118_abnormal_lipid_homeostasis | 0.45831456 |
| 142 | MP0003186_abnormal_redox_activity | 0.44905729 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Rhinitis (HP:0012384) | 9.75782139 |
| 2 | Bronchiectasis (HP:0002110) | 7.31901596 |
| 3 | Nasal polyposis (HP:0100582) | 6.84356802 |
| 4 | Hyperactive renin-angiotensin system (HP:0000841) | 6.50806273 |
| 5 | Pustule (HP:0200039) | 6.33478727 |
| 6 | Right ventricular cardiomyopathy (HP:0011663) | 6.20664600 |
| 7 | Abnormality of the nasal mucosa (HP:0000433) | 5.88645524 |
| 8 | Flat acetabular roof (HP:0003180) | 5.68368063 |
| 9 | Metabolic alkalosis (HP:0200114) | 5.26378411 |
| 10 | Abnormality of chloride homeostasis (HP:0011422) | 4.97539474 |
| 11 | Malnutrition (HP:0004395) | 4.83593833 |
| 12 | Abnormality of cochlea (HP:0000375) | 4.62868562 |
| 13 | Bronchitis (HP:0012387) | 4.50207909 |
| 14 | Recurrent sinusitis (HP:0011108) | 4.27991239 |
| 15 | Abnormal tarsal ossification (HP:0008369) | 4.24977734 |
| 16 | Infertility (HP:0000789) | 4.07077771 |
| 17 | Prostate neoplasm (HP:0100787) | 4.03611475 |
| 18 | Abnormality of the 1st metacarpal (HP:0010009) | 3.95464096 |
| 19 | Chronic sinusitis (HP:0011109) | 3.95404712 |
| 20 | Abnormality of small intestinal villus morphology (HP:0011472) | 3.92996958 |
| 21 | Villous atrophy (HP:0011473) | 3.92996958 |
| 22 | Alopecia of scalp (HP:0002293) | 3.88605560 |
| 23 | Vacuolated lymphocytes (HP:0001922) | 3.84011966 |
| 24 | Recurrent otitis media (HP:0000403) | 3.79561838 |
| 25 | Abdominal distention (HP:0003270) | 3.72448518 |
| 26 | Ileus (HP:0002595) | 3.68108916 |
| 27 | Abnormality of renin-angiotensin system (HP:0000847) | 3.65962184 |
| 28 | Hyperaldosteronism (HP:0000859) | 3.60844741 |
| 29 | Abnormal foot bone ossification (HP:0010675) | 3.36635739 |
| 30 | Onycholysis (HP:0001806) | 3.36341039 |
| 31 | Chronic otitis media (HP:0000389) | 3.10895941 |
| 32 | Occipital encephalocele (HP:0002085) | 3.10770288 |
| 33 | Morphological abnormality of the inner ear (HP:0011390) | 3.06690460 |
| 34 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 3.05337892 |
| 35 | Woolly hair (HP:0002224) | 3.04499353 |
| 36 | Abnormality of the 2nd finger (HP:0004100) | 3.01578863 |
| 37 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 2.99737483 |
| 38 | Fragile nails (HP:0001808) | 2.96840658 |
| 39 | Atelectasis (HP:0100750) | 2.95457377 |
| 40 | Pili torti (HP:0003777) | 2.93489471 |
| 41 | Abnormality of carpal bone ossification (HP:0006257) | 2.92333582 |
| 42 | Dehydration (HP:0001944) | 2.88156615 |
| 43 | Oligomenorrhea (HP:0000876) | 2.87573046 |
| 44 | Decreased circulating renin level (HP:0003351) | 2.81558694 |
| 45 | Short 1st metacarpal (HP:0010034) | 2.81515048 |
| 46 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 2.81515048 |
| 47 | Milia (HP:0001056) | 2.80560249 |
| 48 | Hypokalemia (HP:0002900) | 2.76961916 |
| 49 | Alkalosis (HP:0001948) | 2.67232370 |
| 50 | Aortic aneurysm (HP:0004942) | 2.65231896 |
| 51 | True hermaphroditism (HP:0010459) | 2.64510136 |
| 52 | Pancreatic fibrosis (HP:0100732) | 2.62562948 |
| 53 | Short phalanx of the thumb (HP:0009660) | 2.57389231 |
| 54 | Cheilitis (HP:0100825) | 2.55556988 |
| 55 | Flattened epiphyses (HP:0003071) | 2.52358250 |
| 56 | Micronodular cirrhosis (HP:0001413) | 2.48500426 |
| 57 | Shawl scrotum (HP:0000049) | 2.48346229 |
| 58 | Biliary tract neoplasm (HP:0100574) | 2.46429832 |
| 59 | Rectal prolapse (HP:0002035) | 2.45214434 |
| 60 | Short hallux (HP:0010109) | 2.40158084 |
| 61 | Atrophic scars (HP:0001075) | 2.37430236 |
| 62 | Cystic liver disease (HP:0006706) | 2.36038235 |
| 63 | Plantar hyperkeratosis (HP:0007556) | 2.35000369 |
| 64 | Hyperkalemia (HP:0002153) | 2.32701003 |
| 65 | Palpitations (HP:0001962) | 2.30984006 |
| 66 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 2.29882832 |
| 67 | Hyponatremia (HP:0002902) | 2.29606702 |
| 68 | Abnormal ossification of hand bones (HP:0005921) | 2.27242608 |
| 69 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.27152389 |
| 70 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 2.18493123 |
| 71 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.17223953 |
| 72 | Abnormal hand bone ossification (HP:0010660) | 2.15667873 |
| 73 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.15062807 |
| 74 | Microretrognathia (HP:0000308) | 2.14823418 |
| 75 | Ventricular tachycardia (HP:0004756) | 2.14428682 |
| 76 | Dysostosis multiplex (HP:0000943) | 2.13206090 |
| 77 | Renal salt wasting (HP:0000127) | 2.10538036 |
| 78 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.10246761 |
| 79 | Aplasia/Hypoplasia of the phalanges of the thumb (HP:0009658) | 2.09855449 |
| 80 | Chronic diarrhea (HP:0002028) | 2.09642574 |
| 81 | Cupped ribs (HP:0000887) | 2.08693080 |
| 82 | Abnormality of potassium homeostasis (HP:0011042) | 2.08400780 |
| 83 | Widely patent fontanelles and sutures (HP:0004492) | 2.08349388 |
| 84 | Abnormal biliary tract morphology (HP:0012440) | 2.06953902 |
| 85 | Neonatal short-limb short stature (HP:0008921) | 2.06110266 |
| 86 | Abnormality of midbrain morphology (HP:0002418) | 2.02540706 |
| 87 | Molar tooth sign on MRI (HP:0002419) | 2.02540706 |
| 88 | Tubulointerstitial nephritis (HP:0001970) | 2.01589413 |
| 89 | Pancreatic cysts (HP:0001737) | 2.01272115 |
| 90 | Abnormality of magnesium homeostasis (HP:0004921) | 2.01148812 |
| 91 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 11.9738039 |
| 92 | Abnormal respiratory epithelium morphology (HP:0012253) | 10.5845359 |
| 93 | Abnormal respiratory motile cilium morphology (HP:0005938) | 10.5845359 |
| 94 | Abnormal respiratory motile cilium physiology (HP:0012261) | 10.4240950 |
| 95 | Absent/shortened dynein arms (HP:0200106) | 10.1844477 |
| 96 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 10.1844477 |
| 97 | Abnormal ciliary motility (HP:0012262) | 10.0957545 |
| 98 | Petechiae (HP:0000967) | 1.99921992 |
| 99 | Hypomagnesemia (HP:0002917) | 1.99855894 |
| 100 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.99459113 |
| 101 | Congenital, generalized hypertrichosis (HP:0004540) | 1.98176919 |
| 102 | Nephronophthisis (HP:0000090) | 1.96197820 |
| 103 | Recurrent bronchitis (HP:0002837) | 1.94833394 |
| 104 | Aplasia/hypoplasia of the femur (HP:0005613) | 1.94812221 |
| 105 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.94482549 |
| 106 | Chronic bronchitis (HP:0004469) | 1.94356722 |
| 107 | Bell-shaped thorax (HP:0001591) | 1.94224920 |
| 108 | Cone-rod dystrophy (HP:0000548) | 1.93759890 |
| 109 | Curly hair (HP:0002212) | 1.92977627 |
| 110 | Abnormal vertebral ossification (HP:0100569) | 1.91663716 |
| 111 | Ureteral stenosis (HP:0000071) | 1.91497982 |
| 112 | Abnormal cartilage morphology (HP:0002763) | 1.89029199 |
| 113 | Chronic hepatic failure (HP:0100626) | 1.88324896 |
| 114 | Postaxial foot polydactyly (HP:0001830) | 1.88166837 |
| 115 | Ureteral obstruction (HP:0006000) | 1.88083844 |
| 116 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 1.86576376 |
| 117 | Vertebral hypoplasia (HP:0008417) | 1.86576376 |
| 118 | Hypokalemic alkalosis (HP:0001949) | 1.85913843 |
| 119 | Beaking of vertebral bodies (HP:0004568) | 1.85715264 |
| 120 | Hyperparathyroidism (HP:0000843) | 1.84630004 |
| 121 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 1.82372376 |
| 122 | Abnormality of sodium homeostasis (HP:0010931) | 1.82147846 |
| 123 | Hoarse voice (HP:0001609) | 1.81784428 |
| 124 | Aortic dissection (HP:0002647) | 1.78016716 |
| 125 | Gastrointestinal dysmotility (HP:0002579) | 1.77606250 |
| 126 | Adrenal overactivity (HP:0002717) | 1.75120913 |
| 127 | Esophageal varix (HP:0002040) | 1.73791380 |
| 128 | Facial shape deformation (HP:0011334) | 1.73742250 |
| 129 | Potter facies (HP:0002009) | 1.73742250 |
| 130 | Myopathic facies (HP:0002058) | 1.72344522 |
| 131 | Tracheal stenosis (HP:0002777) | 1.70392077 |
| 132 | Proximal tubulopathy (HP:0000114) | 1.70125480 |
| 133 | Male infertility (HP:0003251) | 1.69605046 |
| 134 | Absent frontal sinuses (HP:0002688) | 1.63321039 |
| 135 | Abnormality of the renal medulla (HP:0100957) | 1.58914077 |
| 136 | Congenital hepatic fibrosis (HP:0002612) | 1.58434274 |
| 137 | Nephropathy (HP:0000112) | 1.52188395 |
| 138 | Male pseudohermaphroditism (HP:0000037) | 1.52172941 |
| 139 | Spinal cord compression (HP:0002176) | 1.49054570 |
| 140 | Tubular atrophy (HP:0000092) | 1.48327602 |
| 141 | Anencephaly (HP:0002323) | 1.42736280 |
| 142 | Furrowed tongue (HP:0000221) | 1.41456238 |
| 143 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.41333471 |
| 144 | Vascular calcification (HP:0004934) | 1.40799038 |
| 145 | Popliteal pterygium (HP:0009756) | 1.39976379 |
| 146 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.39918824 |
| 147 | Asplenia (HP:0001746) | 1.39628362 |
| 148 | Hand muscle atrophy (HP:0009130) | 1.39356864 |
| 149 | Abnormality of the dental root (HP:0006486) | 1.38518929 |
| 150 | Taurodontia (HP:0000679) | 1.38518929 |
| 151 | Abnormality of permanent molar morphology (HP:0011071) | 1.38518929 |
| 152 | Short nail (HP:0001799) | 1.38086039 |
| 153 | Glucose intolerance (HP:0000833) | 1.35753424 |
| 154 | Short thorax (HP:0010306) | 1.32247742 |
| 155 | Hypotension (HP:0002615) | 1.30400361 |
| 156 | Lip pit (HP:0100267) | 1.28251076 |
| 157 | Abnormality of molar morphology (HP:0011070) | 1.27187858 |
| 158 | Abnormality of molar (HP:0011077) | 1.27187858 |
| 159 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.24664201 |
| 160 | Bifid scrotum (HP:0000048) | 1.24428234 |
| 161 | Oculomotor apraxia (HP:0000657) | 1.23598138 |
| 162 | Abnormality of the dental pulp (HP:0006479) | 1.22178747 |
| 163 | Upper limb amyotrophy (HP:0009129) | 1.21406268 |
| 164 | Distal upper limb amyotrophy (HP:0007149) | 1.21406268 |
| 165 | Cardiovascular calcification (HP:0011915) | 1.20838073 |
| 166 | Medial flaring of the eyebrow (HP:0010747) | 1.19210914 |
| 167 | Congenital primary aphakia (HP:0007707) | 1.15364226 |
| 168 | Distal lower limb muscle weakness (HP:0009053) | 1.14847584 |
| 169 | Short femoral neck (HP:0100864) | 1.14794473 |
| 170 | Sclerocornea (HP:0000647) | 1.14019003 |
| 171 | Ventricular fibrillation (HP:0001663) | 1.12569578 |
| 172 | Fat malabsorption (HP:0002630) | 1.11209828 |
| 173 | Hemorrhage of the eye (HP:0011885) | 1.10157046 |
| 174 | Gait imbalance (HP:0002141) | 1.09372676 |
| 175 | Stridor (HP:0010307) | 1.09168788 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAPK15 | 8.82667441 |
| 2 | MST1R | 7.75482605 |
| 3 | PIK3CA | 7.08779936 |
| 4 | MAP3K2 | 4.14014445 |
| 5 | FRK | 3.57816390 |
| 6 | MST4 | 3.51783026 |
| 7 | LMTK2 | 3.20400066 |
| 8 | KSR2 | 3.08828837 |
| 9 | MAP2K2 | 2.91299262 |
| 10 | MET | 2.90493258 |
| 11 | AKT3 | 2.89371915 |
| 12 | TAOK3 | 2.88713350 |
| 13 | SMG1 | 2.34903514 |
| 14 | STK24 | 2.24162087 |
| 15 | MYLK | 2.18236591 |
| 16 | STK39 | 2.09503582 |
| 17 | NME1 | 1.95961921 |
| 18 | EEF2K | 1.80330266 |
| 19 | EPHA2 | 1.74634120 |
| 20 | TESK1 | 1.64043731 |
| 21 | MAP2K1 | 1.50019189 |
| 22 | PRKG2 | 1.42741583 |
| 23 | ACVR1B | 1.38531741 |
| 24 | EPHB2 | 1.36811380 |
| 25 | MAP3K12 | 1.35010011 |
| 26 | OXSR1 | 1.27496590 |
| 27 | EPHA3 | 1.13397930 |
| 28 | ERN1 | 1.12588387 |
| 29 | LATS1 | 1.10302250 |
| 30 | CAMK2D | 1.08916715 |
| 31 | RPS6KB2 | 1.08270505 |
| 32 | NEK6 | 1.06170002 |
| 33 | PDK2 | 1.01052074 |
| 34 | BCR | 0.99691083 |
| 35 | PTK2B | 0.96159892 |
| 36 | TBK1 | 0.94714724 |
| 37 | FER | 0.94184393 |
| 38 | NUAK1 | 0.91345515 |
| 39 | BCKDK | 0.88492670 |
| 40 | DMPK | 0.87447187 |
| 41 | MAPKAPK3 | 0.85835167 |
| 42 | PTK6 | 0.80060102 |
| 43 | MAP3K8 | 0.78935459 |
| 44 | STK38 | 0.75860281 |
| 45 | MAPKAPK5 | 0.74291024 |
| 46 | ICK | 0.73098545 |
| 47 | LRRK2 | 0.70867700 |
| 48 | TRPM7 | 0.70770545 |
| 49 | TTN | 0.70447455 |
| 50 | PIK3CG | 0.69721682 |
| 51 | MAP3K1 | 0.67895457 |
| 52 | DDR2 | 0.67704065 |
| 53 | PRKCI | 0.67589876 |
| 54 | MARK2 | 0.64973922 |
| 55 | STK10 | 0.62818157 |
| 56 | LIMK1 | 0.60833589 |
| 57 | RIPK1 | 0.56731463 |
| 58 | TAOK1 | 0.54090766 |
| 59 | ERBB3 | 0.53692923 |
| 60 | SCYL2 | 0.53414827 |
| 61 | FGFR3 | 0.52525439 |
| 62 | MATK | 0.51492245 |
| 63 | FGFR4 | 0.50923082 |
| 64 | WNK4 | 0.50727672 |
| 65 | TESK2 | 0.50582262 |
| 66 | SIK1 | 0.49146514 |
| 67 | WNK1 | 0.48263383 |
| 68 | PRKCD | 0.46160665 |
| 69 | TYK2 | 0.46003498 |
| 70 | PTK2 | 0.45728318 |
| 71 | RET | 0.45123318 |
| 72 | ZAP70 | 0.42437479 |
| 73 | IRAK1 | 0.41941459 |
| 74 | PBK | 0.41465922 |
| 75 | NLK | 0.40327654 |
| 76 | CAMKK1 | 0.39623038 |
| 77 | HIPK2 | 0.39342738 |
| 78 | CDK3 | 0.38969830 |
| 79 | ABL2 | 0.37530422 |
| 80 | ROCK1 | 0.37447504 |
| 81 | TLK1 | 0.37352563 |
| 82 | ERBB2 | 0.35876366 |
| 83 | JAK2 | 0.35098164 |
| 84 | PRKCQ | 0.32042167 |
| 85 | CDK9 | 0.31666354 |
| 86 | TRIB3 | 0.30377798 |
| 87 | CAMK2G | 0.28959130 |
| 88 | AURKB | 0.28479325 |
| 89 | PIM2 | 0.28272932 |
| 90 | DYRK1B | 0.28227626 |
| 91 | SGK1 | 0.28124579 |
| 92 | PDPK1 | 0.27695579 |
| 93 | PAK2 | 0.27440914 |
| 94 | BRSK2 | 0.26836764 |
| 95 | PNCK | 0.26081007 |
| 96 | ROCK2 | 0.25627233 |
| 97 | DAPK3 | 0.25278184 |
| 98 | CAMK2B | 0.24663511 |
| 99 | MAP2K6 | 0.23263773 |
| 100 | EPHB1 | 0.22957075 |
| 101 | GRK1 | 0.22405651 |
| 102 | TTK | 0.21361317 |
| 103 | MAP3K3 | 0.20683769 |
| 104 | CDK6 | 0.20402925 |
| 105 | GRK6 | 0.19919487 |
| 106 | PAK4 | 0.19797064 |
| 107 | SRC | 0.19088676 |
| 108 | PAK1 | 0.18932911 |
| 109 | CSK | 0.18929899 |
| 110 | FYN | 0.18466343 |
| 111 | FGFR2 | 0.18336906 |
| 112 | RPS6KA2 | 0.17894255 |
| 113 | PRKCA | 0.17632648 |
| 114 | ARAF | 0.17317826 |
| 115 | ILK | 0.17221444 |
| 116 | MAP3K7 | 0.15681697 |
| 117 | CDC42BPA | 0.15010523 |
| 118 | PKN2 | 0.14106503 |
| 119 | BMPR2 | 0.13949039 |
| 120 | ABL1 | 0.13610972 |
| 121 | IGF1R | 0.13498962 |
| 122 | MAP3K10 | 0.13426152 |
| 123 | YES1 | 0.13325124 |
| 124 | AKT2 | 0.11390435 |
| 125 | PDK1 | 0.11200124 |
| 126 | PRKD2 | 0.11077098 |
| 127 | PRKAA2 | 0.10341552 |
| 128 | MELK | 0.10184467 |
| 129 | PRKAA1 | 0.08925816 |
| 130 | SGK3 | 0.08484548 |
| 131 | TNK2 | 0.08052203 |
| 132 | PDGFRA | 0.07800665 |
| 133 | PDGFRB | 0.07716782 |
| 134 | RIPK4 | 0.07689296 |
| 135 | STK38L | 0.07167076 |
| 136 | RPS6KA1 | 0.06369305 |
| 137 | PAK3 | 0.05901876 |
| 138 | STK3 | 0.05853909 |
| 139 | ADRBK1 | 0.05814064 |
| 140 | MAPKAPK2 | 0.05158244 |
| 141 | PHKG1 | 0.04353383 |
| 142 | PHKG2 | 0.04353383 |
| 143 | CAMK1D | 0.04057764 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sulfur metabolism_Homo sapiens_hsa00920 | 7.75675437 |
| 2 | Mineral absorption_Homo sapiens_hsa04978 | 4.05015401 |
| 3 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 3.47095336 |
| 4 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.77887346 |
| 5 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.53226802 |
| 6 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.25875754 |
| 7 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.22502287 |
| 8 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 2.21577912 |
| 9 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 2.08460107 |
| 10 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 2.00780344 |
| 11 | Bile secretion_Homo sapiens_hsa04976 | 1.90226711 |
| 12 | Tight junction_Homo sapiens_hsa04530 | 1.78753402 |
| 13 | Sulfur relay system_Homo sapiens_hsa04122 | 1.70570915 |
| 14 | Other glycan degradation_Homo sapiens_hsa00511 | 1.63682719 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.61441084 |
| 16 | Thyroid cancer_Homo sapiens_hsa05216 | 1.54946764 |
| 17 | Histidine metabolism_Homo sapiens_hsa00340 | 1.53420565 |
| 18 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.52063144 |
| 19 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.47087483 |
| 20 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.46213943 |
| 21 | Salivary secretion_Homo sapiens_hsa04970 | 1.45213273 |
| 22 | Bladder cancer_Homo sapiens_hsa05219 | 1.38952383 |
| 23 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.36943481 |
| 24 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.34932336 |
| 25 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.34440142 |
| 26 | Huntingtons disease_Homo sapiens_hsa05016 | 1.30873640 |
| 27 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.27969295 |
| 28 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.25203237 |
| 29 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.22912905 |
| 30 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.20966271 |
| 31 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.20265258 |
| 32 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.20122098 |
| 33 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.18732802 |
| 34 | Adherens junction_Homo sapiens_hsa04520 | 1.16558782 |
| 35 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.14475101 |
| 36 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.13512461 |
| 37 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.10782190 |
| 38 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.09450098 |
| 39 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.06878066 |
| 40 | Hepatitis C_Homo sapiens_hsa05160 | 1.00680140 |
| 41 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.96464840 |
| 42 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.95037147 |
| 43 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.94776907 |
| 44 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.94709038 |
| 45 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.94282851 |
| 46 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.92907689 |
| 47 | Alzheimers disease_Homo sapiens_hsa05010 | 0.92602681 |
| 48 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.91793435 |
| 49 | Peroxisome_Homo sapiens_hsa04146 | 0.90298638 |
| 50 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.87651568 |
| 51 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.83897279 |
| 52 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.83785326 |
| 53 | ABC transporters_Homo sapiens_hsa02010 | 0.82886362 |
| 54 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.81525471 |
| 55 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.80595152 |
| 56 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.76869584 |
| 57 | Salmonella infection_Homo sapiens_hsa05132 | 0.74739032 |
| 58 | Endometrial cancer_Homo sapiens_hsa05213 | 0.73607667 |
| 59 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.73284052 |
| 60 | Galactose metabolism_Homo sapiens_hsa00052 | 0.71463321 |
| 61 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.68817853 |
| 62 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.68053236 |
| 63 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.63376872 |
| 64 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.63124534 |
| 65 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.63009445 |
| 66 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.62412458 |
| 67 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.62232545 |
| 68 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.62179967 |
| 69 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.61682776 |
| 70 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.60423946 |
| 71 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.55765397 |
| 72 | Amoebiasis_Homo sapiens_hsa05146 | 0.52666073 |
| 73 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.51363142 |
| 74 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.51237266 |
| 75 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.50246450 |
| 76 | Parkinsons disease_Homo sapiens_hsa05012 | 0.49795616 |
| 77 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.48879194 |
| 78 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.48393634 |
| 79 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.47934350 |
| 80 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.46908938 |
| 81 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.46816600 |
| 82 | Prostate cancer_Homo sapiens_hsa05215 | 0.45347642 |
| 83 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.44703312 |
| 84 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.43715752 |
| 85 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.42213030 |
| 86 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.41015791 |
| 87 | Focal adhesion_Homo sapiens_hsa04510 | 0.40580663 |
| 88 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.40578062 |
| 89 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.40532912 |
| 90 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.39873584 |
| 91 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.38251467 |
| 92 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.37568232 |
| 93 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.37535928 |
| 94 | Gap junction_Homo sapiens_hsa04540 | 0.37425633 |
| 95 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.35645724 |
| 96 | Asthma_Homo sapiens_hsa05310 | 0.35370347 |
| 97 | Insulin resistance_Homo sapiens_hsa04931 | 0.34588778 |
| 98 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.33720850 |
| 99 | Allograft rejection_Homo sapiens_hsa05330 | 0.32743243 |
| 100 | Circadian rhythm_Homo sapiens_hsa04710 | 0.32021140 |
| 101 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.31760179 |
| 102 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.31703113 |
| 103 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.31665925 |
| 104 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.31253854 |
| 105 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.30308800 |
| 106 | Protein export_Homo sapiens_hsa03060 | 0.29884252 |
| 107 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.27377540 |
| 108 | Metabolic pathways_Homo sapiens_hsa01100 | 0.27303443 |
| 109 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.26017497 |
| 110 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.25127137 |
| 111 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.25086542 |
| 112 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.24783432 |
| 113 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.24613131 |
| 114 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.24327076 |
| 115 | Influenza A_Homo sapiens_hsa05164 | 0.24089473 |
| 116 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.23962163 |
| 117 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.23910463 |
| 118 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.22634940 |
| 119 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.22467111 |
| 120 | Retinol metabolism_Homo sapiens_hsa00830 | 0.21864070 |
| 121 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.20948864 |
| 122 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.20744801 |
| 123 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.20260499 |
| 124 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.19916293 |
| 125 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.19373447 |
| 126 | Lysosome_Homo sapiens_hsa04142 | 0.19236685 |
| 127 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.18513775 |
| 128 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.16040448 |
| 129 | Endocytosis_Homo sapiens_hsa04144 | 0.15982205 |
| 130 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.14452609 |
| 131 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.12814211 |
| 132 | Renin secretion_Homo sapiens_hsa04924 | 0.11836139 |
| 133 | Taste transduction_Homo sapiens_hsa04742 | 0.11723122 |
| 134 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.11599078 |

